Suchergebnisse - "Serna-Gallego, Ana"

PubPharm (22)

1

HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Muñoz-Muela, E. | Trujillo-Rodríguez, M. | Serna-Gallego, A. | +4

2

Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Saborido-Alconchel, A. | Serna-Gallego, A. | Lopez-Cortes, L. | +11

ErratumIn: J Antimicrob Chemother. 2023 Nov 03;:. - PMID 37935622

3

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered

enthalten in: Frontiers in immunology | 2023

von López-Cortés, L. | Saborido-Alconchel, A. | Trujillo-Rodríguez, M. | +9

4

Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Trujillo-Rodríguez, M. | Muñoz-Muela, E. | Serna-Gallego, A. | +11

5

Anti-CD4 autoantibodies in immunological nonresponder people with HIV : cause of CD4 + T-cell depletion?

enthalten in: AIDS (London, England) | 2022

von Muñoz-Muela, E. | Trujillo-Rodríguez, M. | Serna-Gallego, A. | +6

CommentIn: AIDS. 2023 Mar 1;37(3):553-554. - PMID 36695367

6

Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response

enthalten in: bioRxiv.org | 2022

von Pérez-Gómez, A. | Gasca-Capote, M. | Vitallé, J. | +22

7

Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response

enthalten in: Clinical and translational medicine | 2022

von Pérez-Gómez, A. | Gasca-Capote, C. | Vitallé, J. | +23

8

Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients

enthalten in: PloS one | 2022

von Trujillo-Rodriguez, M. | Muñoz-Muela, E. | Serna-Gallego, A. | +13

9

Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response

enthalten in: Clinical and Translational Medicine | 2022

von Pérez‐Gómez, A. | Gasca‐Capote, C. | Vitallé, J. | +22

10

Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19

enthalten in: Microorganisms | 2021

von Codina, H. | Vieitez, I. | Gutierrez-Valencia, A. | +14